Cite
HARVARD Citation
Groenendijk, A. et al. (2022). Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only − the SIOP 93–01 and 2001 protocols. European journal of cancer. pp. 88-97. [Online].